Clinical Trial Update: Anti-viral Action Against Type 1 Diabetes Autoimmunity [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial, sponsored by Technical University of Munich, is investigating an antiviral approach to Type 1 diabetes autoimmunity and is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Technical University of Munich | Conditions: Diabetes Mellitus, Type 1 | Phase 4 | Status: RECRUITING